AU1734895A
(en)
*
|
1994-03-08 |
1995-09-25 |
Genetics Institute Inc. |
Methods and compositions for treatment of periodontal disease and repair of periodontal lesions
|
US5626861A
(en)
*
|
1994-04-01 |
1997-05-06 |
Massachusetts Institute Of Technology |
Polymeric-hydroxyapatite bone composite
|
US6369116B1
(en)
|
1995-06-02 |
2002-04-09 |
Oculex Pharmaceuticals, Inc. |
Composition and method for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5674292A
(en)
*
|
1995-06-07 |
1997-10-07 |
Stryker Corporation |
Terminally sterilized osteogenic devices and preparation thereof
|
NZ503548A
(en)
*
|
1996-02-09 |
2001-09-28 |
Amgen Inc |
A fusion protein comprising an IL-1ra receptor antagonist with a constant domain of human immunoglobulin at the carboxy terminus
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
ZA9711580B
(en)
*
|
1996-12-25 |
1999-09-23 |
Hoechst Marion Roussel Ltd |
Process for the production of purified dimeric bone morphogenetic factors.
|
EP0957943B2
(en)
*
|
1997-02-07 |
2008-11-26 |
Stryker Corporation |
Matrix-free osteogenic devices, implants and methods of use thereof
|
AU779278B2
(en)
*
|
1997-02-07 |
2005-01-13 |
Stryker Corporation |
Matrix-free osteogenic devices, implants and methods of use thereof
|
US7041641B2
(en)
*
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
US20010016646A1
(en)
|
1998-03-20 |
2001-08-23 |
David C. Rueger |
Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
|
US6071982A
(en)
*
|
1997-04-18 |
2000-06-06 |
Cambridge Scientific, Inc. |
Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same
|
AU7260598A
(en)
*
|
1997-04-28 |
1998-11-24 |
Trustees Of The University Of Pennsylvania, The |
Method for promoting myogenesis using osteogenic proteins
|
US6391336B1
(en)
|
1997-09-22 |
2002-05-21 |
Royer Biomedical, Inc. |
Inorganic-polymer complexes for the controlled release of compounds including medicinals
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
TWI239847B
(en)
*
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
US20080050367A1
(en)
*
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US6787523B1
(en)
*
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US7790856B2
(en)
*
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
US20050059802A1
(en)
*
|
1998-04-07 |
2005-03-17 |
Neuralab Ltd |
Prevention and treatment of amyloidogenic disease
|
MXPA01003538A
(es)
*
|
1998-10-06 |
2005-09-08 |
Rush Presbyterian St Luke |
Metodo para el tratamiento de quimionucleolisis.
|
DE19906096A1
(de)
|
1999-02-13 |
2000-08-17 |
Walter Sebald |
Protein mit einem Heparin-bindenden Epitop
|
US7371408B1
(en)
*
|
1999-06-07 |
2008-05-13 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US7052856B2
(en)
*
|
1999-10-05 |
2006-05-30 |
The Regents Of The University Of California |
NELL-1 enhanced bone mineralization
|
US20090060988A1
(en)
*
|
1999-10-05 |
2009-03-05 |
Kang Ting |
Nell-1 enhanced bone mineralization
|
US7884066B2
(en)
*
|
1999-10-05 |
2011-02-08 |
The Regents Of The University Of California |
NELL-1 enhanced bone mineralization
|
WO2004024893A2
(en)
*
|
2002-09-13 |
2004-03-25 |
The Regents Of The University Of California |
Nell-1 enhanced bone mineralization
|
US7687462B2
(en)
*
|
1999-10-05 |
2010-03-30 |
The Regents Of The University Of California |
Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition
|
EP1155704A1
(en)
*
|
2000-01-13 |
2001-11-21 |
Chih-I Lin |
Orthopedic filling material and method of use thereof
|
US6630153B2
(en)
*
|
2001-02-23 |
2003-10-07 |
Smith & Nephew, Inc. |
Manufacture of bone graft substitutes
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
SE517168C2
(sv)
*
|
2000-07-17 |
2002-04-23 |
Bone Support Ab |
En komposition för ett injicerbart ersättningsmaterial för benmineral
|
US20080233165A1
(en)
*
|
2000-08-07 |
2008-09-25 |
Biolok International, Inc. |
Time release calcium sulfate and growth factor matrix for bone augmentation
|
BR0115772A
(pt)
|
2000-11-29 |
2004-01-13 |
Oculex Pharm Inc |
Processos para a redução ou para a prevenção da rejeição ao transplante ocular e de implantes intraoculares para uso para o mesmo
|
TWI255272B
(en)
*
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
US6949251B2
(en)
*
|
2001-03-02 |
2005-09-27 |
Stryker Corporation |
Porous β-tricalcium phosphate granules for regeneration of bone tissue
|
US20020169066A1
(en)
*
|
2001-04-16 |
2002-11-14 |
Cerabio, L.L.C. |
Dense porous structures for use as bone substitutes
|
US20060263401A1
(en)
*
|
2001-07-13 |
2006-11-23 |
Flow Focusing, Inc. |
Formulation and Method for Preventing Infection
|
US20050129732A1
(en)
*
|
2001-07-13 |
2005-06-16 |
Flow Focusing, Inc. |
Biodegradable, antibiotic, controlled release tape
|
US20070254009A1
(en)
*
|
2001-07-13 |
2007-11-01 |
Flow Focusing, Inc. |
Antibiotic/bone morphogenic protein formulation and method of treatment
|
US20070254008A1
(en)
*
|
2001-07-13 |
2007-11-01 |
Flow Focusing, Inc. |
Antibiotic formulation and method of treatment
|
US7371409B2
(en)
*
|
2001-09-06 |
2008-05-13 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
DK1448246T4
(en)
*
|
2001-11-19 |
2015-12-21 |
Scil Technology Gmbh |
Homogeneously coated device with osteoinductive and osteoconductive properties
|
WO2003066000A2
(en)
*
|
2002-02-08 |
2003-08-14 |
Wyeth |
Formulation comprising bioactive agents and method of using same
|
MY139983A
(en)
*
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
AU2003258172B2
(en)
|
2002-03-29 |
2008-02-28 |
Wright Medical Technolgy, Inc. |
Bone graft substitute composition
|
US6652887B1
(en)
|
2002-06-24 |
2003-11-25 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US7291179B2
(en)
*
|
2002-06-24 |
2007-11-06 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US20040002770A1
(en)
*
|
2002-06-28 |
2004-01-01 |
King Richard S. |
Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof
|
US20040023322A1
(en)
*
|
2002-08-01 |
2004-02-05 |
Goodheart Clyde R. |
Method of producing non-recombinant BMP-2 and use thereof
|
US7029006B2
(en)
*
|
2002-08-29 |
2006-04-18 |
Canon Kabushiki Kaisha |
Sheet feeding apparatus and image forming apparatus
|
US8986737B2
(en)
*
|
2002-09-05 |
2015-03-24 |
Wm. Marsh Rice University |
Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
|
CN100522241C
(zh)
*
|
2002-09-10 |
2009-08-05 |
Scil技术股份有限公司 |
在低氧气浓度下用骨诱导蛋白包被的金属植入物
|
AU2003286472A1
(en)
|
2002-10-17 |
2004-05-04 |
Alkermes Controlled Therapeutics, Inc. Ii |
Microencapsulation and sustained release of biologically active polypeptides
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
JP2006516639A
(ja)
*
|
2003-02-01 |
2006-07-06 |
ニユーララブ・リミテツド |
可溶性A−βに対する抗体を生成させるための能動免疫
|
US7507257B2
(en)
*
|
2003-02-04 |
2009-03-24 |
Wright Medical Technology, Inc. |
Injectable resorbable bone graft material, powder for forming same and methods relating thereto for treating bone defects
|
EP1594889B1
(en)
*
|
2003-02-07 |
2011-04-06 |
The Regents of The University of California |
Nell peptide expression systems and bone formation activity of nell peptide
|
PE20050627A1
(es)
*
|
2003-05-30 |
2005-08-10 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido beta amiloideo
|
CA2529503A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Royer Biomedical, Inc. |
Drug polymer complexes
|
US20040262809A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Smith Todd S. |
Crosslinked polymeric composite for orthopaedic implants
|
EP1677735B1
(en)
|
2003-10-17 |
2014-07-23 |
Joslin Diabetes Center, Inc. |
Methods and compositions for modulating adipocyte function
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US8328876B2
(en)
|
2003-12-31 |
2012-12-11 |
Warsaw Orthopedic, Inc. |
Bone matrix compositions and methods
|
US20070231788A1
(en)
*
|
2003-12-31 |
2007-10-04 |
Keyvan Behnam |
Method for In Vitro Assay of Demineralized Bone Matrix
|
US8734525B2
(en)
|
2003-12-31 |
2014-05-27 |
Warsaw Orthopedic, Inc. |
Osteoinductive demineralized cancellous bone
|
JP2007518804A
(ja)
|
2004-01-20 |
2007-07-12 |
アラーガン、インコーポレイテッド |
トリアムシノロンアセトニドおよびヒアルロン酸を好ましく含有する眼局所治療用組成物
|
US8377904B2
(en)
*
|
2004-02-09 |
2013-02-19 |
Hill's Pet Nutrition, Inc. |
Composition and method for use in cartilage affecting conditions
|
US7691607B2
(en)
*
|
2004-02-09 |
2010-04-06 |
The Regents Of The University Of California |
Expression system of NELL peptide
|
EP2409707B8
(en)
*
|
2004-04-15 |
2015-05-06 |
Alkermes Pharma Ireland Limited |
Polymer-based sustained release device
|
US7456254B2
(en)
*
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
BRPI0510485A
(pt)
|
2004-04-30 |
2007-11-13 |
Allergan Inc |
implantes inibidores de tirosina cinase intravìtreos biodegradáveis
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US8455656B2
(en)
|
2004-04-30 |
2013-06-04 |
Allergan, Inc. |
Kinase inhibitors
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US20050244472A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
US20050244463A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US7384430B2
(en)
*
|
2004-06-30 |
2008-06-10 |
Depuy Products, Inc. |
Low crystalline polymeric material for orthopaedic implants and an associated method
|
BRPI0513243B8
(pt)
*
|
2004-07-12 |
2021-05-25 |
Allergan Inc |
composições oftálmicas e respectivos usos
|
EP3508201A3
(en)
*
|
2004-08-09 |
2019-10-16 |
Enrique Melendez Hevia |
Glycine as a diet supplement for use in the treatment skin problems that result from underlying collagen disorders and and cosmetic uses thereof
|
WO2006043965A1
(en)
*
|
2004-10-14 |
2006-04-27 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US7250550B2
(en)
*
|
2004-10-22 |
2007-07-31 |
Wright Medical Technology, Inc. |
Synthetic bone substitute material
|
CA2589017A1
(en)
*
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Amyloid beta antibodies for use in improving cognition
|
JP2008523815A
(ja)
*
|
2004-12-15 |
2008-07-10 |
エラン ファーマ インターナショナル リミテッド |
認知の改善における使用のためのヒト化アミロイドβ抗体
|
PE20061152A1
(es)
*
|
2004-12-15 |
2006-10-13 |
Neuralab Ltd |
Anticuerpos humanizados que reconocen el peptido beta amiloideo
|
US7883653B2
(en)
|
2004-12-30 |
2011-02-08 |
Depuy Products, Inc. |
Method of making an implantable orthopaedic bearing
|
US7896921B2
(en)
*
|
2004-12-30 |
2011-03-01 |
Depuy Products, Inc. |
Orthopaedic bearing and method for making the same
|
US7879275B2
(en)
*
|
2004-12-30 |
2011-02-01 |
Depuy Products, Inc. |
Orthopaedic bearing and method for making the same
|
SV2008002394A
(es)
*
|
2005-01-28 |
2008-02-08 |
Wyeth Corp |
Formulaciones liquidas estabilizadas de polipeptido ref. ahn- 072sv
|
GT200600031A
(es)
*
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
EP1851237A4
(en)
|
2005-02-16 |
2009-01-07 |
Univ California |
PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING BONE DISORDERS
|
EP1855732A1
(fr)
*
|
2005-02-24 |
2007-11-21 |
Roland Dricot |
Implant osseux
|
WO2006130690A2
(en)
|
2005-06-01 |
2006-12-07 |
Joslin Diabetes Center, Inc. |
Methods and compositions for inducing brown adipogenesis
|
US20060286171A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Tianhong Zhou |
Bone morphogenetic protein formulations
|
US7754246B2
(en)
|
2005-09-09 |
2010-07-13 |
Wright Medical Technology, Inc. |
Composite bone graft substitute cement and articles produced therefrom
|
US8025903B2
(en)
|
2005-09-09 |
2011-09-27 |
Wright Medical Technology, Inc. |
Composite bone graft substitute cement and articles produced therefrom
|
ES2393756T3
(es)
*
|
2005-11-01 |
2012-12-27 |
Warsaw Orthopedic, Inc. |
Métodos para producir composiciones de matriz ósea
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
US8784810B2
(en)
*
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
WO2007136664A2
(en)
*
|
2006-05-16 |
2007-11-29 |
Flow Focusing, Inc. |
Antibiotic formulation and method of treatment
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8197840B2
(en)
*
|
2006-07-21 |
2012-06-12 |
Genera Istrazivanja D.O.O. |
Whole blood-derived coagulum device for treating bone defects
|
EP2046361A4
(en)
*
|
2006-07-26 |
2011-06-29 |
Univ California |
AMPLIFICATION COMPOSITION OF OSTEOGENIC ACTIVITY
|
US20080051796A1
(en)
*
|
2006-08-01 |
2008-02-28 |
Warsaw Orthopedic, Inc. |
Graft retention tack
|
WO2008021133A2
(en)
|
2006-08-09 |
2008-02-21 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
AU2007234612B2
(en)
*
|
2006-12-14 |
2013-06-27 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein stabilization formulations
|
DE102006060958A1
(de)
*
|
2006-12-20 |
2008-06-26 |
Jennissen, Herbert P., Prof. Dr. |
Verfahren zur Herstellung einer Polymermatrix, daraus bestehende Implantate sowie deren Verwendung
|
CA2680365A1
(en)
*
|
2007-03-22 |
2008-10-02 |
Alkermes, Inc. |
Coacervation process
|
JP2011526240A
(ja)
*
|
2007-04-18 |
2011-10-06 |
ヤンセン アルツハイマー イミュノセラピー |
脳アミロイド血管症の予防および治療
|
US8003097B2
(en)
*
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
EP2157967B1
(en)
|
2007-04-23 |
2013-01-16 |
Intarcia Therapeutics, Inc |
Suspension formulations of insulinotropic peptides and uses thereof
|
EP2144624A1
(en)
*
|
2007-05-15 |
2010-01-20 |
Stryker Corporation |
Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
|
WO2008157497A2
(en)
*
|
2007-06-15 |
2008-12-24 |
Osteotech, Inc. |
Method of treating tissue
|
WO2008157495A2
(en)
|
2007-06-15 |
2008-12-24 |
Osteotech, Inc. |
Bone matrix compositions and methods
|
US9554920B2
(en)
*
|
2007-06-15 |
2017-01-31 |
Warsaw Orthopedic, Inc. |
Bone matrix compositions having nanoscale textured surfaces
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
US20110054408A1
(en)
*
|
2007-07-10 |
2011-03-03 |
Guobao Wei |
Delivery systems, devices, tools, and methods of use
|
WO2009009684A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Osteotech, Inc. |
Delivery system
|
EP2182983B1
(en)
|
2007-07-27 |
2014-05-21 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases with humanised anti-abeta antibodies
|
US8058237B2
(en)
*
|
2007-08-07 |
2011-11-15 |
Advanced Technologies & Regenerative Medicine, LLC |
Stable composition of GDF-5 and method of storage
|
JO3076B1
(ar)
*
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
WO2009052492A2
(en)
*
|
2007-10-19 |
2009-04-23 |
Osteotech, Inc. |
Demineralized bone matrix compositions and methods
|
DE102007051914A1
(de)
*
|
2007-10-29 |
2009-05-07 |
Herbert Prof. Dr. Jennissen |
Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
EP2276458A1
(en)
*
|
2008-04-14 |
2011-01-26 |
Advanced Technologies and Regenerative Medicine, LLC |
Liquid buffered gdf-5 formulations
|
US9616153B2
(en)
*
|
2008-04-17 |
2017-04-11 |
Warsaw Orthopedic, Inc. |
Rigid bone graft substitute
|
CA2725208A1
(en)
*
|
2008-05-06 |
2009-11-12 |
Joslin Diabetes Center, Inc. |
Methods and compositions for inducing brown adipogenesis
|
US9492375B2
(en)
*
|
2008-07-23 |
2016-11-15 |
Warsaw Orthopedic, Inc. |
Foam carrier for bone grafting
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
WO2010093955A1
(en)
*
|
2009-02-12 |
2010-08-19 |
Osteotech,Inc. |
Segmented delivery system
|
WO2010138637A2
(en)
|
2009-05-26 |
2010-12-02 |
The Regents Of The University Of California |
Fibromodulin peptide
|
CN104323981B
(zh)
|
2009-09-28 |
2019-03-12 |
精达制药公司 |
基本稳态药物递送的快速建立和/或终止
|
US20120322882A1
(en)
|
2009-11-09 |
2012-12-20 |
Allergan, Inc. |
Compositions And Methods For Stimulating Hair Growth
|
JP5669050B2
(ja)
*
|
2010-01-15 |
2015-02-12 |
国立大学法人島根大学 |
骨セメント
|
US9180137B2
(en)
|
2010-02-09 |
2015-11-10 |
Bone Support Ab |
Preparation of bone cement compositions
|
US9358323B2
(en)
*
|
2010-04-29 |
2016-06-07 |
Warsaw Orthopedic, Inc. |
Flowable ceramic putty
|
CA2798710C
(en)
|
2010-05-11 |
2019-08-27 |
Venkat R. Garigapati |
Organophosphorous, multivalent metal compounds, & polymer adhesive interpenetrating network compositions & methods
|
EP2606121B1
(en)
|
2010-08-19 |
2016-05-11 |
The Regents of The University of California |
Compositions comrpising perivascular stem cells and nell-1 protein
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
AU2012243410B8
(en)
|
2011-04-11 |
2016-11-17 |
Red Rock Regeneration Inc. |
System and method for multiphasic release of growth factors
|
WO2012158527A2
(en)
|
2011-05-13 |
2012-11-22 |
Howmedica Osteonics |
Organophosphorous & multivalent metal compound compositions & methods
|
CN104220046A
(zh)
|
2012-04-11 |
2014-12-17 |
感应生物制品股份有限公司 |
用于生长因子多相释放的体系和方法
|
EP2956096A1
(en)
|
2013-02-15 |
2015-12-23 |
Allergan, Inc. |
Sustained drug delivery implant
|
DK2958603T3
(en)
|
2013-02-20 |
2018-07-16 |
Bone Support Ab |
IMPROVED CURE FOR HARDWARE BONE COMPENSATION
|
TWI651103B
(zh)
|
2013-12-13 |
2019-02-21 |
萊特醫技股份有限公司 |
多相骨移植替代材料
|
RS59285B1
(sr)
|
2014-03-20 |
2019-10-31 |
Stayble Therapeutics Ab |
Kompozicija za upotrebu u lečenju bola povezanog sa intervertebralnim diskom
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
EP3240563B1
(en)
*
|
2014-12-29 |
2020-12-09 |
Bioventus LLC |
Systems and methods for improved delivery of osteoinductive molecules in bone repair
|
WO2016196851A2
(en)
|
2015-06-03 |
2016-12-08 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
CN108601864A
(zh)
|
2015-10-30 |
2018-09-28 |
佰欧维恩图斯有限责任公司 |
用于增强骨修复中骨诱导分子的递送的基质
|
MX2018014016A
(es)
|
2016-05-16 |
2019-08-01 |
Intarcia Therapeutics Inc |
Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos.
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
CN109310801A
(zh)
|
2016-06-10 |
2019-02-05 |
佰欧维恩图斯有限责任公司 |
使用多孔金属结构的蛋白递送
|
CN110225762A
(zh)
|
2017-01-03 |
2019-09-10 |
因塔西亚制药公司 |
包括glp-1受体激动剂的连续施用和药物的共同施用的方法
|
US11103618B2
(en)
|
2018-02-22 |
2021-08-31 |
Warsaw Orthopedic, Inc. |
Demineralized bone matrix having improved handling characteristics
|